Advanced search
Publication Cover
Cancer Biology & Therapy Volume 16, 2015 - Issue 8
Submit an article Journal homepage
1,558
Views
40
CrossRef citations to date
0
Altmetric
Research Paper

ABC294640, a sphingosine kinase 2 inhibitor, enhances the antitumor effects of TRAIL in non-small cell lung cancer

Jie YangDepartment of Radiation and Medical Oncology; Zhongnan Hospital of Wuhan University; Wuhan, PR China
,
Chunxu YangDepartment of Radiation and Medical Oncology; Zhongnan Hospital of Wuhan University; Wuhan, PR China
,
Shimin ZhangDepartment of Radiation and Medical Oncology; Zhongnan Hospital of Wuhan University; Wuhan, PR China
,
Zijie MeiDepartment of Radiation and Medical Oncology; Zhongnan Hospital of Wuhan University; Wuhan, PR China
,
Mingjun ShiHubei Key Laboratory of Tumor Biological Behaviors; Zhongnan Hospital; Wuhan University; Wuhan, PR China
,
Shaoxing SunDepartment of Radiation and Medical Oncology; Zhongnan Hospital of Wuhan University; Wuhan, PR China
,
Liu ShiDepartment of Radiation and Medical Oncology; Zhongnan Hospital of Wuhan University; Wuhan, PR China
,
Zhihao WangDepartment of Radiation and Medical Oncology; Zhongnan Hospital of Wuhan University; Wuhan, PR China
,
Yacheng WangDepartment of Radiation and Medical Oncology; Zhongnan Hospital of Wuhan University; Wuhan, PR China
,
Zhenzhen LiDepartment of Radiation and Medical Oncology; Zhongnan Hospital of Wuhan University; Wuhan, PR China
&
Conghua XieDepartment of Radiation and Medical Oncology; Zhongnan Hospital of Wuhan University; Wuhan, PR China;Hubei Key Laboratory of Tumor Biological Behaviors; Zhongnan Hospital; Wuhan University; Wuhan, PR ChinaCorrespondence[email protected]
 show all
Pages 1194-1204 | Received 23 Jan 2015, Accepted 26 May 2015, Published online: 28 Jul 2015

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related Research Data

Synthesis and biological evaluation of sphingosine kinase 2 inhibitors with anti-inflammatory activity.
Source: Wiley
New insights into the roles and regulation of SphK2 as a therapeutic target in cancer chemoresistance.
Source: Wiley
Sphingosine kinase 2 supports the development of BCR/ABL-independent acute lymphoblastic leukemia in mice
Source: Springer Science and Business Media LLC
LC-MS based sphingolipidomic study on A549 human lung adenocarcinoma cell line and its taxol-resistant strain
Source: Springer Science and Business Media LLC
Targeting sphingosine-1-phosphate signaling for cancer therapy
Source: Springer Science and Business Media LLC
Targeting sphingosine kinase 2 (SphK2) by ABC294640 inhibits colorectal cancer cell growth in vitro and in vivo
Source: Springer Nature

Linking provided by 

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.